Screener
Hemab Therapeutics Holdings, Inc. COAG Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax (expense) benefit | (97) | (4) | (109) | 186 |
| Net loss | $(24,150) | $(12,209) | $(46,837) | $(27,515) |
| Net loss per share, basic and diluted | $(0.80) | $(12.91) | $(3.00) | $(29.09) |
| Weighted average shares outstanding, basic and diluted | 30,111,338 | 946,000 | 15,609,236 | 946,000 |
| Other comprehensive loss | ||||
| Net loss | $(24,150) | $(12,209) | $(46,837) | $(27,515) |
| Net unrealized (loss) gain on available-for-sale debt securities | (2,309) | (609) | (2,923) | 365 |
| Total comprehensive loss | $(26,459) | $(12,818) | $(49,760) | $(27,150) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s shares (diluted)?
- Hemab Therapeutics Holdings, Inc. (COAG) reported shares (diluted) of 30.1M in Q2 2026.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude